Congenital Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Congenital Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus [Phase 1]
A Phase 1 safety assessment of oral letermovir in infants with symptomatic congenital cytomegalovirus infection is underway.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy [NA]
A completed clinical trial evaluated a prenatal behavioral intervention aimed at preventing maternal cytomegalovirus infection and congenita…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - CYMEVALIII STEP1 [NA]
A completed clinical trial evaluating prenatal Letermovir versus Valaciclovir for the treatment of congenital cytomegalovirus infection.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir [Phase 3]
A Phase 3 clinical trial comparing Letermovir to Valaciclovir for prenatal treatment of congenital cytomegalovirus infection is currently re…
-
CLINICAL_TRIALS other · 2026-03-30Clinical Trial Update: CMV CTLs in Neonates With CMV Infection [Phase 2]
This clinical trial update describes a Phase 2 study evaluating CMV-specific cytotoxic T lymphocytes (CMV CTLs) in neonates with congenital …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening [NA]
Clinical trial NCT02139423 has completed and investigated diagnostic methods for congenital cytomegalovirus infection in neonates who failed…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women With Primary HCMV Infection.
This clinical trial is investigating immunological and virological prognostic markers to predict outcomes of congenital cytomegalovirus infe…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection [Phase 4]
Phase 4 clinical trial evaluating the long-term efficacy of a 4- to 6-month antiviral therapy for neurodevelopmental impairments caused by c…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation [NA]
This completed clinical trial update discusses cytomegalovirus vaccines and challenges related to reinfection and antigenic variation. The s…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero [NA]
A completed clinical trial assessing whether neonatal biomarkers can predict neurosensorial sequelae in children with congenital CMV infecti…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir [Phase 4]
This clinical trial update notes the completion of a Phase 4 study investigating in utero treatment of congenital cytomegalovirus infection …
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Long-Term Outcomes of Children With Congenital CMV in New York State
Ongoing clinical trial in New York State assessing long-term outcomes in children with congenital cytomegalovirus infection, including senso…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) [Phase 3]
A Phase 3 trial (PreCyssion) evaluating prevention of maternal-fetal cytomegalovirus transmission after primary maternal infection in early …
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Cytomegalovirus Shedding Characteristics in Pregnant Women
The document notes that a clinical trial studying cytomegalovirus shedding in pregnant women has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) [Phase 3]
A phase 3 randomized trial investigated strategies to prevent congenital cytomegalovirus infection, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Asymptomatic Congenital CMV Treatment [Phase 2]
A Phase 2 trial evaluating treatment for asymptomatic congenital cytomegalovirus infection was terminated; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment [Phase 3]
Phase 3 trial update on antiviral treatment for congenital cytomegalovirus infection with sensorineural hearing loss; study completed.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss [Phase 2]
Phase 2 clinical trial evaluating valganciclovir therapy in infants and children with congenital cytomegalovirus infection and hearing loss …
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance [Phase 2, Phase 3]
Phase 2/3 trial evaluating valganciclovir for reducing CMV-related deafness in congenital CMV infection; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy [Phase 2, Phase 3]
A clinical trial evaluating valacyclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnan…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Screening for Congenital Cytomegalovirus Infection in Newborns
A clinical trial evaluating screening for congenital cytomegalovirus infection in newborns has completed.
-
CLINICAL_TRIALS research · 2018-05-07Clinical Trial Update: A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
A completed cross-sectional study examining congenital cytomegalovirus infection in newborns in China.
-
CLINICAL_TRIALS withdrawal · 2018-03-01Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine [Phase 1]
Phase 1 trial evaluating safety, tolerability, and immunogenicity of a cytomegalovirus DNA vaccine for congenital CMV infection; the study h…
-
CLINICAL_TRIALS research · 2017-06-15Clinical Trial Update: Development of Potential Biomarkers for Foetal Brain Development After Congenital CMV Infection [NA]
Clinical trial update focusing on developing biomarkers to monitor fetal brain development after congenital cytomegalovirus infection.
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
The trial investigates placental transfer of anti-CMV IgG and anti-VZV IgG antibodies to premature and full-term newborns. Current status of…